#FDA#iRobot#InTouch Health#RP-VITA#IRBT#FDA

iRobot receives FDA approval

Follow @AbbyPhillips89 iRobot Corp (IRBT), a leader in delivering robotic solutions, announced today that RP-VITA Remote Presence Robot has received 5...

Admin
|Jan 25|magazine5 min read

 

iRobot Corp (IRBT), a leader in delivering robotic solutions, announced today that RP-VITA Remote Presence Robot has received 510(k) clearance by the US Food and Drug Administration (FDA) for use in hospitals. iRobot’s RP-VITA is the first autonomous navigation remote presence robot to receive FDA clearance.

Since the announcement was made, IRBT shares increased from $2.21, or 10.5%, to $23.32.

RP-VITA was developed by iRobot and InTouch Health and combines the latest in autonomous navigation and mobility technologies as well as state-of-the-art telemedicine and electronic health record integration.

In a nutshell, the robot will allow doctors to visit hospital patients remotely. They will be able to view and communicate with the patient via a high-tech iPad application.

According to iRobot, the FDA clearance states RP-VITA ‘can be used for active patient monitoring in pre-operative, peri-operative and post-surgical settings, including cardiovascular, neurological, prenatal, psychological and critical care assessments and examinations.’

This is the first robot to be cleared for everyday use in a hospital setting, sparking a new development in the way we access and communicate with medical professionals in the future.

 

 

How do you feel about iRobot’s latest clearance? Join the discussion on Twitter @HealthCareG